ARCHIVES

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984

Itri Pays Fine, Agrees Not to Serve As Company Officer for Five Years

April 25, 2014

House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments

August 4, 1995

CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials

November 11, 1983

Trials Could Start Earlier If Model Contract Language Adopted, NCI and CEO Roundtable Say.

December 12, 2008